United States · FDA National Drug Code directory

Pedia-Lax

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0132-0202_c91936fa-4bac-4586-98c9-f98b805350b4
Product NDC
0132-0202
Form
ENEMA
Composition / generic term
sodium phosphate, dibasic and sodium phosphate, monobasic
Labeler
C.B. Fleet Company, Inc.
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20020510
Source listing expiry
20261231

Source-listed ingredients

  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE — 3.5 g/66mL
  • SODIUM PHOSPHATE, MONOBASIC — 9.5 g/66mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 66 mL in 1 BOTTLE, WITH APPLICATOR (0132-0202-20) · 0132-0202-20

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Pedia-Lax — United States | Molindra Medicines